Interventions to Support Engagement in Addiction Care Postpartum: Principles and Pitfalls

References

• Admon LK, Zivin K, Kozhimannil KB. Perinatal insurance coverage and behavioural health-related maternal mortality. Int Rev Psychiatry. 2021;33(6):553–556. doi:10.1080/09540261.2021.1903843
   PubMed Web of Science ®Google Scholar
• Interrante JD, Admon LK, Carroll C, Henning-Smith C, Chastain P, Kozhimannil KB. Association of health insurance, geography, and race and ethnicity with disparities in receipt of recommended postpartum care in the US. JAMA Health Forum. 2022;3(10):e223292. doi:10.1001/jamahealthforum.2022.3292
   PubMedGoogle Scholar
• CDC. Opioid use disorder and pregnancy. Centers for Disease Control and Prevention; 2022. Available from: https://www.cdc.gov/pregnancy/opioids/treatment.html. Accessed February 1, 2023.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. A collaborative approach to the treatment of pregnant women with opioid use disorders. Substance Abuse and Mental Health Services Administration; 2016. Available from: https://store.samhsa.gov/product/A-Collaborative-Approach-to-the-Treatment-of-Pregnant-Women-with-Opioid-Use-Disorders/SMA16-4978. Accessed September 4, 2019.
   Google Scholar
• American Society of Addiction Medicine, The American College of Obstetricians and Gynecologists’ Committee on obstetric practice. ACOG Committee Opinion: Opioid Use and Opioid Use Disorder in Pregnancy; 2017. Available from: https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-and-Opioid-Use-Disorder-in-Pregnancy. Accessed May 19, 2019.
   Google Scholar
• Harter K. Opioid use disorder in pregnancy. Ment Health Clin. 2019;9(6):359–372. doi:10.9740/mhc.2019.11.359
   PubMedGoogle Scholar
• Wachman EM, Saia K, Miller M, et al. Naltrexone treatment for pregnant women with opioid use disorder compared with matched buprenorphine control subjects. Clin Ther. 2019;41(9):1681–1689. doi:10.1016/j.clinthera.2019.07.003
   PubMed Web of Science ®Google Scholar
• Ecker J, Abuhamad A, Hill W, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol. 2019;221(1):B5–B28. doi:10.1016/j.ajog.2019.03.022
   PubMed Web of Science ®Google Scholar
• Ellis LP, Parlier-Ahmad AB, Scheikl M, Martin CE. An integrated care model for pregnant and postpartum individuals receiving medication for opioid use disorder. J Addict Med. 2023;17(2):131–139. doi:10.1097/ADM.0000000000001052
   PubMed Web of Science ®Google Scholar
• Saia KA, Schiff D, Wachman EM, et al. Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment. Curr Obstet Gynecol Rep. 2016;5(3):257–263. doi:10.1007/s13669-016-0168-9
   PubMedGoogle Scholar
• The Society for Adolescent Health and Medicine. Medication for adolescents and young adults with opioid use disorder (position paper). J Adolesc Health. 2021;68(3):632–636. doi:10.1016/j.jadohealth.2020.12.129
   PubMed Web of Science ®Google Scholar
• Cunningham C, Edlund MJ, Fishman M, et al. The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med. 2020;14(2S):1. doi:10.1097/ADM.0000000000000633
   Google Scholar
• Terplan M, Laird HJ, Hand DJ, et al. Opioid detoxification during pregnancy: a systematic review. Obstet Gynecol. 2018;131(5):803–814. doi:10.1097/AOG.0000000000002562
   PubMed Web of Science ®Google Scholar
• Jones HE, Jansson LM, O’Grady KE, Kaltenbach K. The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations. Neurotoxicol Teratol. 2013;39:110–115. doi:10.1016/j.ntt.2013.05.003
   PubMed Web of Science ®Google Scholar
• Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–2331. doi:10.1056/NEJMoa1005359
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2):CD002207. doi:10.1002/14651858.CD002207.pub4
   PubMed Web of Science ®Google Scholar
• Krans EE, Kim JY, Chen Q, et al. [coding hypertensive/other things] Outcomes associated with the use of medications for opioid use disorder during pregnancy. Addict Abingdon Engl. 2021;116(12):3504–3514. doi:10.1111/add.15582
   PubMed Web of Science ®Google Scholar
• Rizk AH, Simonsen SE, Roberts L, Taylor-Swanson L, Lemoine JB, Smid M. Maternity care for pregnant women with opioid use disorder: a review. J Midwifery Womens Health. 2019;64(5):532–544. doi:10.1111/jmwh.13019
   PubMed Web of Science ®Google Scholar
• Pond SM, Kreek MJ, Tong TG, Raghunath J, Benowitz NL. Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther. 1985;233(1):1–6.
   PubMed Web of Science ®Google Scholar
• McCarthy JJ, Jones HE, Terplan M, Rudolf VP, von Klimo MC. Changing outdated methadone regulations that harm pregnant patients. J Addict Med. 2021;15(2):93–95. doi:10.1097/ADM.0000000000000720
   PubMed Web of Science ®Google Scholar
• McCarthy JJ, Vasti EJ, Leamon MH, Graas J, Ward C, Fassbender C. The use of serum methadone/metabolite ratios to monitor changing perinatal pharmacokinetics. J Addict Med. 2018;12(3):241–246. doi:10.1097/ADM.0000000000000398
   PubMed Web of Science ®Google Scholar
• Clemans-Cope L, Lynch V, Howell E, et al. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013–2016. Drug Alcohol Depend. 2019;195:156–163. doi:10.1016/j.drugalcdep.2018.12.005
   PubMed Web of Science ®Google Scholar
• Krans EE, Kim JY, James AE, Kelley D, Jarlenski MP. Medication-assisted treatment use among pregnant women with opioid use disorder. Obstet Gynecol. 2019;133(5):943–951. doi:10.1097/AOG.0000000000003231
   PubMed Web of Science ®Google Scholar
• Guille C, Simpson AN, Douglas E, et al. Treatment of opioid use disorder in pregnant women via telemedicine: a nonrandomized controlled trial. JAMA Netw Open. 2020;3(1):e1920177. doi:10.1001/jamanetworkopen.2019.20177
   PubMed Web of Science ®Google Scholar
• Schiff DM, Nielsen TC, Hoeppner BB, et al. Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder. Am J Obstet Gynecol. 2021;225(4):424.e1–424.e12. doi:10.1016/j.ajog.2021.04.210
   PubMed Web of Science ®Google Scholar
• Short VL, Cambareri K, Gannon M, Alexander K, Abatemarco DJ. A pilot study to assess breastfeeding knowledge, attitudes, and perceptions of individuals who work in perinatal opioid use disorder treatment settings. Breastfeed Med. 2019;14(5):307–312. doi:10.1089/bfm.2018.0257
   PubMed Web of Science ®Google Scholar
• Collins M. Breastfeeding recommendations for people who use substances: AWHONN practice brief number 16. J Obstet Gynecol Neonatal Nurs. 2023;52(1):e1–e4. doi:10.1016/j.jogn.2022.08.003
   PubMed Web of Science ®Google Scholar
• Godersky ME, Saxon AJ, Merrill JO, Samet JH, Simoni JM, Tsui JI. Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence. Addict Sci Clin Pract. 2019;14(1):11. doi:10.1186/s13722-019-0139-3
   PubMedGoogle Scholar
• Feder KA, Mojtabai R, Musci RJ, Letourneau EJ. U.S. adults with opioid use disorder living with children: treatment use and barriers to care. J Subst Abuse Treat. 2018;93:31–37. doi:10.1016/j.jsat.2018.07.011
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services Assistant Secretary for Planning and Evaluation Office of Disability. State policy levers for expanding family-centered medication-assisted treatment. Aging and Long-Term Care Policy; 2019:1–55. Available from: https://aspe.hhs.gov/sites/default/files/migrated_legacy_files//187076/ExpandFCMAT.pdf. Accessed June 27, 2023.
   Google Scholar
• Syvertsen JL, Toneff H, Howard H, Spadola C, Madden D, Clapp J. Conceptualizing stigma in contexts of pregnancy and opioid misuse: a qualitative study with women and healthcare providers in Ohio. Drug Alcohol Depend. 2021;222:108677. doi:10.1016/j.drugalcdep.2021.108677
   PubMed Web of Science ®Google Scholar
• Skaggs P, Bell SB, Scutchfield FD, Robinson LE. Providers’ stigmas and the effects on patients with opioid use disorder: a scoping review. J Appalachian Health. 2022. doi:10.13023/JAH.0403.06
   Google Scholar
• Patrick SW, Richards MR, Dupont WD, et al. Association of pregnancy and insurance status with treatment access for opioid use disorder. JAMA Netw Open. 2020;3(8):e2013456–e2013456. doi:10.1001/jamanetworkopen.2020.13456
   PubMed Web of Science ®Google Scholar
• Patrick SW, Schiff DM, Ryan SA, Quigley J, Gonzalez PK, Walker LR. A public health response to opioid use in pregnancy. Pediatrics. 2017;139(3):e20164070. doi:10.1542/peds.2016-4070
   PubMed Web of Science ®Google Scholar
• Goodrich DE, Kilbourne AM, Nord KM, Bauer MS. Mental health collaborative care and its role in primary care settings. Curr Psychiatry Rep. 2013;15(8):383. doi:10.1007/s11920-013-0383-2
   PubMed Web of Science ®Google Scholar
• Weaver MR, Conover CJ, Proescholdbell RJ, et al. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders. J Ment Health Policy Econ. 2009;12(1):33–46.
   PubMed Web of Science ®Google Scholar
• Beichler H, Grabovac I, Dorner TE. Integrated care as a model for interprofessional disease management and the benefits for people living with HIV/AIDS. Int J Environ Res Public Health. 2023;20(4):3374. doi:10.3390/ijerph20043374
   PubMedGoogle Scholar
• Milligan K, Niccols A, Sword W, Thabane L, Henderson J, Smith A. Birth outcomes for infants born to women participating in integrated substance abuse treatment programs: a meta-analytic review. Addict Res Theory. 2011;19(6):542–555. doi:10.3109/16066359.2010.545153
   Web of Science ®Google Scholar
• Goodman DJ, Saunders EC, Frew JR, et al. Integrated vs nonintegrated treatment for perinatal opioid use disorder: retrospective cohort study. Am J Obstet Gynecol MFM. 2022;4(1):100489. doi:10.1016/j.ajogmf.2021.100489
   PubMed Web of Science ®Google Scholar
• Katon WJ. The Institute of Medicine “Chasm” report: implications for depression collaborative care models. Gen Hosp Psychiatry. 2003;25(4):222–229. doi:10.1016/s0163-8343(03)00064-1
   PubMed Web of Science ®Google Scholar
• Huffman JC, Niazi SK, Rundell JR, Sharpe M, Katon WJ. Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the Academy of Psychosomatic Medicine Research and Evidence-based Practice Committee. Psychosomatics. 2014;55(2):109–122. doi:10.1016/j.psym.2013.09.002
   PubMed Web of Science ®Google Scholar
• Huang H, Tabb KM, Cerimele JM, Ahmed N, Bhat A, Kester R. Collaborative care for women with depression: a systematic review. Psychosomatics. 2017;58(1):11–18. doi:10.1016/j.psym.2016.09.002
   PubMed Web of Science ®Google Scholar
• Freytsis M, Phillippi JC, Cox KJ, Romano A, Cragin L. The American College of Nurse-midwives clarity in collaboration project: describing midwifery care in interprofessional collaborative care models. J Midwifery Womens Health. 2017;62(1):101–108. doi:10.1111/jmwh.12521
   PubMed Web of Science ®Google Scholar
• Allen EC, Sakowicz A, Parzyszek CL, McDonald A, Miller ES. The association between engagement in a perinatal collaborative care program and breastfeeding among people with identified mental health conditions. Am J Obstet Gynecol MFM. 2022;4(3):100591. doi:10.1016/j.ajogmf.2022.100591
   PubMed Web of Science ®Google Scholar
• Miller ES, Grobman WA, Ciolino JD, et al. Increased depression screening and treatment recommendations after implementation of a perinatal collaborative care program. Psychiatr Serv Wash DC. 2021;72(11):1268–1275. doi:10.1176/appi.ps.202000563
   PubMed Web of Science ®Google Scholar
• Hensel D, Helou NE, Zhang F, et al. The impact of a multidisciplinary opioid use disorder prenatal clinic on breastfeeding rates and postpartum care. Am J Perinatol. 2022. doi:10.1055/s-0042-1748526
   Web of Science ®Google Scholar
• Hodgins FE, Lang JM, Malseptic GG, Melby LH, Connolly KA. Coordinating outpatient care for pregnant and postpartum women with opioid use disorder: implications from the COACHH program. Matern Child Health J. 2019;23(5):585–591. doi:10.1007/s10995-018-2683-y
   PubMed Web of Science ®Google Scholar
• Mittal L, Suzuki J. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy. Subst Abuse. 2017;38(3):261–264. doi:10.1080/08897077.2015.1129525
   PubMed Web of Science ®Google Scholar
• Iddins BW, Frank JS, Kannar P, et al. Evaluation of team-based care in an urban free clinic setting. Nurs Adm Q. 2015;39(3):254–262. doi:10.1097/NAQ.0000000000000103
   PubMedGoogle Scholar
• Keshmiri F, Rezai M, Tavakoli N. The effect of interprofessional education on healthcare providers’ intentions to engage in interprofessional shared decision-making: perspectives from the theory of planned behaviour. J Eval Clin Pract. 2020;26(4):1153–1161. doi:10.1111/jep.13379
   PubMed Web of Science ®Google Scholar
• Hargraves IG, Fournier AK, Montori VM, Bierman AS. Generalized shared decision making approaches and patient problems. Adapting AHRQ’s SHARE approach for purposeful SDM. Patient Educ Couns. 2020;103(10):2192–2199. doi:10.1016/j.pec.2020.06.022
   PubMed Web of Science ®Google Scholar
• Guille C, Jones HE, Abuhamad A, Brady KT. Shared decision-making tool for treatment of perinatal opioid use disorder. Psychiatr Res Clin Pract. 2019;1(1):27–31. doi:10.1176/appi.prcp.20180004
   PubMedGoogle Scholar
• Principles of Harm Reduction. National harm reduction coalition. Available from: https://harmreduction.org/about-us/principles-of-harm-reduction/. Accessed April 25, 2023.
   Google Scholar
• Hawk KF, Vaca FE, D’Onofrio G. Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies. Yale J Biol Med. 2015;88(3):235–245.
   PubMedGoogle Scholar
• Castillo T. Harm reduction strategies for the opiod crisis. N C Med J. 2018;79(3):192–194. doi:10.18043/ncm.79.3.192
   PubMedGoogle Scholar
• Escañuela Sánchez T, Matvienko-Sikar K, Linehan L, O’Donoghue K, Byrne M, Meaney S. Facilitators and barriers to substance-free pregnancies in high-income countries: a meta-synthesis of qualitative research. Women Birth J Aust Coll Midwives. 2022;35(2):e99–e110. doi:10.1016/j.wombi.2021.04.010
   PubMed Web of Science ®Google Scholar
• Wolfson L, Schmidt RA, Stinson J, Poole N. Examining barriers to harm reduction and child welfare services for pregnant women and mothers who use substances using a stigma action framework. Health Soc Care Community. 2021;29(3):589–601. doi:10.1111/hsc.13335
   PubMed Web of Science ®Google Scholar
• Blanton TL, Deschner J. Biological mothers’ grief: the postadoptive experience in open versus confidential adoption. Child Welfare. 1990;69(6):525–535.
   PubMed Web of Science ®Google Scholar
• Kenny KS, Barrington C, Green SL. “I felt for a long time like everything beautiful in me had been taken out”: women’s suffering, remembering, and survival following the loss of child custody. Int J Drug Policy. 2015;26(11):1158–1166. doi:10.1016/j.drugpo.2015.05.024
   PubMed Web of Science ®Google Scholar
• Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25(6):611–624. doi:10.1080/09595230600944529
   PubMed Web of Science ®Google Scholar
• Brown HL. Opioid management in pregnancy and postpartum. Obstet Gynecol Clin North Am. 2020;47(3):421–427. doi:10.1016/j.ogc.2020.04.005
   PubMed Web of Science ®Google Scholar
• Rankin L, Mendoza NS, Grisham L. Unpacking perinatal experiences with opioid use disorder: relapse risk implications. Clin Soc Work J. 2023;51(1):34–45. doi:10.1007/s10615-022-00847-x
   Web of Science ®Google Scholar
• El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. People who inject drugs in intimate relationships: it takes two to combat HIV. Curr HIV/AIDS Rep. 2014;11(1):45–51. doi:10.1007/s11904-013-0192-6
   PubMed Web of Science ®Google Scholar
• Morris MD, Andrew E, Tan JY, et al. Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships. PLoS One. 2019;14(5):e0217811. doi:10.1371/journal.pone.0217811
   PubMed Web of Science ®Google Scholar
• Kashak D. An overview of issues, impacts and services for women who are using substances and are pregnant or parenting within the City of Thunder Bay. Thunder Bay Thunder Bay Drug Strategy. 2015.
   Google Scholar
• Mitra S, Rachlis B, Krysowaty B, et al. Potential use of supervised injection services among people who inject drugs in a remote and mid-size Canadian setting. BMC Public Health. 2019;19(1):284. doi:10.1186/s12889-019-6606-7
   PubMedGoogle Scholar
• Daw JR, Winkelman TNA, Dalton VK, Kozhimannil KB, Admon LK. Medicaid expansion improved perinatal insurance continuity for low-income women. Health Aff Proj Hope. 2020;39(9):1531–1539. doi:10.1377/hlthaff.2019.01835
   PubMed Web of Science ®Google Scholar
• Daw JR, Kolenic GE, Dalton VK, et al. Racial and ethnic disparities in perinatal insurance coverage. Obstet Gynecol. 2020;135(4):917–924. doi:10.1097/AOG.0000000000003728
   PubMed Web of Science ®Google Scholar
• McKinney J, Keyser L, Clinton S, Pagliano C. ACOG Committee Opinion No. 736: optimizing postpartum care. Obstet Gynecol. 2018;132(3):784–785. doi:10.1097/AOG.0000000000002849
   PubMed Web of Science ®Google Scholar
• Williams LD, Mackesy-Amiti ME, Latkin C, Boodram B. Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs. Drug Alcohol Depend. 2021;221:108626. doi:10.1016/j.drugalcdep.2021.108626
   PubMed Web of Science ®Google Scholar
• Safe Families for Children (SFFC). Safe families for children evidence-based evaluation; 2021:2. Available from: http://safe-families.org/wp-content/uploads/2021/06/Evidence-based-Summary.pdf. Accessed June 16, 2023.
   Google Scholar
• Fass S. Paid leave in the states: a critical support for low-wage workers and their families. National Center for Children in Poverty (NCCP); 2009. Available from: https://www.nccp.org/publication/paid-leave-in-the-states/. Accessed April 25, 2023.
   Google Scholar
• Reno R, Barnhart S, Gabbe PT. A critical inquiry of breastfeeding attitudes, barriers, and experiences of African American women living in poverty. J Poverty. 2018;22(6):518–536. doi:10.1080/10875549.2018.1496374
   Web of Science ®Google Scholar
• Karriker-Jaffe KJ. Areas of disadvantage: a systematic review of effects of area-level socioeconomic status on substance use outcomes. Drug Alcohol Rev. 2011;30(1):84–95. doi:10.1111/j.1465-3362.2010.00191.x
   PubMed Web of Science ®Google Scholar
• Linton SL, Haley DF, Hunter-Jones J, Ross Z, Cooper HLF. Social causation and neighborhood selection underlie associations of neighborhood factors with illicit drug-using social networks and illicit drug use among adults relocated from public housing. Soc Sci Med. 2017;185:81–90. doi:10.1016/j.socscimed.2017.04.055
   PubMed Web of Science ®Google Scholar
• Hawk M, Coulter RWS, Egan JE, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1):70. doi:10.1186/s12954-017-0196-4
   PubMedGoogle Scholar
• Hyshka E, Morris H, Anderson-Baron J, Nixon L, Dong K, Salvalaggio G. Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital. Drug Alcohol Depend. 2019;204:107523. doi:10.1016/j.drugalcdep.2019.06.025
   PubMed Web of Science ®Google Scholar
• Brown C, Stewart SH. Harm reduction for women in treatment for alcohol use problems: exploring the impact of dominant addiction discourse. Qual Health Res. 2021;31(1):54–69. doi:10.1177/1049732320954396
   PubMed Web of Science ®Google Scholar
• Cioffi CC, Seeley JR. Voluntary pregnancy screening at syringe exchanges: a feasibility study. J Prev Health Promot. 2021;2(1):57–80. doi:10.1177/2632077020973362
   PubMedGoogle Scholar
• White SA, McCourt A, Bandara S, Goodman DJ, Patel E, McGinty EE. Implementation of state laws giving pregnant people priority access to drug treatment programs in the context of coexisting punitive laws. Womens Health Issues. 2023;33(2):117–125. doi:10.1016/j.whi.2022.09.001
   PubMed Web of Science ®Google Scholar
• Faherty LJ, Kranz AM, Russell-Fritch J, Patrick SW, Cantor J, Stein BD. Association of punitive and reporting state policies related to substance use in pregnancy with rates of neonatal abstinence syndrome. JAMA Netw Open. 2019;2(11):e1914078. doi:10.1001/jamanetworkopen.2019.14078
   PubMed Web of Science ®Google Scholar
• Poland ML, Dombrowski MP, Ager JW, Sokol RJ. Punishing pregnant drug users: enhancing the flight from care. Drug Alcohol Depend. 1993;31(3):199–203. doi:10.1016/0376-8716(93)90001-7
   PubMed Web of Science ®Google Scholar
• Mosley EA, Lanning RK. Evidence and guidelines for trauma-informed doula care. Midwifery. 2020;83:102643. doi:10.1016/j.midw.2020.102643
   PubMed Web of Science ®Google Scholar
• Gannon M, Short V, Becker M, et al. Doula engagement and maternal opioid use disorder (OUD): experiences of women in OUD recovery during the perinatal period. Midwifery. 2022;106:103243. doi:10.1016/j.midw.2021.103243
   PubMed Web of Science ®Google Scholar
• Allen L, Wodtke L, Hayward A, Read C, Cyr M, Cidro J. Pregnant and early parenting Indigenous women who use substances in Canada: a scoping review of health and social issues, supports, and strategies. J Ethn Subst Abuse. 2022;1–31. doi:10.1080/15332640.2022.2043799
   PubMed Web of Science ®Google Scholar
• Becker M, Gannon M. The impact of doula-supported care on stress levels of women receiving opioid addiction treatment. Phase 1 Pap 10; 2021. Available from: https://jdc.jefferson.edu/si_hs_2023_phase1/10. Accessed June 27, 2023.
   Google Scholar
• Stubbs JL. Harm reduction throughout the opioid crisis: a community responds. Br Columbia Med J. 2019;2019:61.4.
   Google Scholar
• Bosk EA, Paris R, Hanson KE, Ruisard D, Suchman NE. Innovations in child welfare interventions for caregivers with substance use disorders and their children. Child Youth Serv Rev. 2019;101:99–112. doi:10.1016/j.childyouth.2019.03.040
   PubMed Web of Science ®Google Scholar
• Marchand K, Beaumont S, Westfall J, et al. Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review. Subst Abuse Treat Prev Policy. 2019;14(1):37. doi:10.1186/s13011-019-0227-0
   PubMed Web of Science ®Google Scholar
• Pantridge CE, Charles VA, DeHart DD, et al. A qualitative study of the role of peer support specialists in substance use disorder treatment: examining the types of support provided. Alcohol Treat Q. 2016;34(3):337–353. doi:10.1080/07347324.2016.1182815
   Web of Science ®Google Scholar